# Cabergoline as a Preventive Treatment for Chronic Migraine

> **NCT05525611** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 36 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Cabergoline 0.5 MG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05525611
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-05
- **Primary completion:** 2023-06-13
- **Final completion:** 2023-08-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05525611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05525611, "Cabergoline as a Preventive Treatment for Chronic Migraine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05525611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*